Trial Profile
A phase 1b study to evaluate safety and dosage of Myoblast cell transplant therapy in congestive heart failure patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 03 Mar 2017 New trial record